Tech Watch: PMC-Sierra to buy Passave Inc.

Based on analyst estimates and service provider announcements, it is estimated that between 45-60 million homes worldwide will be connected using Passive Optical Networking technology by 2010.

By SETH FREEDMAN
April 6, 2006 07:35
1 minute read.
tech watch 88

tech watch 88. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

PMC-Sierra Inc. said Wednesday it signed definitive agreement to acquire Passave Inc., a leading developer of system-on-chip semiconductor solutions for the Fiber To The Home access market, for about $300 million in stock. Based on analyst estimates and service provider announcements, it is estimated that between 45 million and 60 million homes worldwide will be connected using Passive Optical Networking technology by 2010. The deal is expected to close within April 2006. PMC-Sierra expects the acquisition will be neutral to earnings in the near-term and accretive within two to three quarters based on expected revenue growth. Partner Communications has selected the Bank of New York to be the new depositary for its ADR (American Depositary Receipt) program. Traded on NASDAQ, each ADR represents one ordinary share of Partner stock. Bank of New York has a 64% market share of the ADR and GDR (Global Depositary Receipt) market. Radvision and Nortel have collaborated to demonstrate an innovative video community application at the CTIA Wireless 2006 Show in Las Vegas. Nortel will supply the core components for the product, which is based on Radvision's Interactive Video Platform. Ra'anana-based Emblaze announced the launch of emoze, a free Push-Email service for any device. Rivaling Research in Motion's Blackberry's products, the emoze system claims to "make email, diary and contact data available to anyone, anywhere" - and at no cost to users. The service will be compatible with any wireless GSM, CDMA or Wi-Fi network. Siano Mobile Silicon has raised around $23 million in Series B funding, through three Israeli venture capital firms and one from the US. Siano, which employs more than 40 persons, produces fabless semiconductors. In another financing, RadView Software Ltd. said it signed definitive financing agreements with Fortissimo Capital Fund GP LP. The agreements provide for a minimum initial investment of $1.5m. and, at the election of the investors, an additional investment of up to $2.25m. The financing will consist of both convertible preferred shares and convertible debt. Nova Measuring Instruments, meanwhile, said it had been targeted by a lawsuit alleging that the Rehovot-based had infringed patents belonging to Nanometrics Inc. Nova said the claims were meritless and pointed to its own patent infringement claim against Nanometrics, suggesting that this latest claim was a tactical ploy in the long-running battle between the two companies.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS